These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 30124134)

  • 1. Efficacy and safety of oral targeted therapies in pulmonary arterial hypertension: a meta-analysis of randomized clinical trials.
    Zheng YG; Ma H; Chen L; Jiang XM; Zhou L; Lin S; Chen SL
    Pulm Circ; 2018; 8(4):2045894018798183. PubMed ID: 30124134
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Oral targeted therapies in the treatment of pulmonary arterial hypertension: a meta-analysis of clinical trials.
    Zheng YG; Ma H; Hu EC; Liu G; Chen G; Xiong CM
    Pulm Pharmacol Ther; 2014 Dec; 29(2):241-9. PubMed ID: 25173912
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Assessment of Clinical Worsening End Points as a Surrogate for Mortality in Pulmonary Arterial Hypertension: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.
    Tremblay É; Gosselin C; Mai V; Lajoie AC; Kilo R; Weatherald J; Lacasse Y; Bonnet S; Lega JC; Provencher S
    Circulation; 2022 Aug; 146(8):597-612. PubMed ID: 35862151
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prostacyclin for pulmonary arterial hypertension.
    Barnes H; Yeoh HL; Fothergill T; Burns A; Humbert M; Williams T
    Cochrane Database Syst Rev; 2019 May; 5(5):CD012785. PubMed ID: 31042010
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prostanoid therapy for pulmonary arterial hypertension: a meta-analysis of survival outcomes.
    Zheng Y; Yang T; Chen G; Hu E; Gu Q; Xiong C
    Eur J Clin Pharmacol; 2014 Jan; 70(1):13-21. PubMed ID: 24026627
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy and Safety of Pulmonary Arterial Hypertension-specific Therapy in Pulmonary Arterial Hypertension: A Meta-analysis of Randomized Controlled Trials.
    Liu HL; Chen XY; Li JR; Su SW; Ding T; Shi CX; Jiang YF; Zhu ZN
    Chest; 2016 Aug; 150(2):353-66. PubMed ID: 27048870
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Meta-analysis of monotherapy versus combination therapy for pulmonary arterial hypertension.
    Fox BD; Shimony A; Langleben D
    Am J Cardiol; 2011 Oct; 108(8):1177-82. PubMed ID: 21864815
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of oral targeted treatments in pulmonary arterial hypertension: A systematic review and meta-analysis.
    Zhu HR; Kuang HY; Li Q; Ji XJ
    Front Cardiovasc Med; 2022; 9():915470. PubMed ID: 35983180
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy and safety of sequential combination therapy for pulmonary arterial hypertension: A meta-analysis of Randomized-Controlled Trials.
    Tan Z; Wu PY; Zhu TT; Su W; Fang ZF
    Pulm Pharmacol Ther; 2022 Oct; 76():102144. PubMed ID: 35918025
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oral 5-aminosalicylic acid for induction of remission in ulcerative colitis.
    Wang Y; Parker CE; Bhanji T; Feagan BG; MacDonald JK
    Cochrane Database Syst Rev; 2016 Apr; 4(4):CD000543. PubMed ID: 27101467
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oral 5-aminosalicylic acid for induction of remission in ulcerative colitis.
    Feagan BG; Macdonald JK
    Cochrane Database Syst Rev; 2012 Oct; 10():CD000543. PubMed ID: 23076889
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Combination Therapy for Pulmonary Arterial Hypertension: A Systematic Review and Meta-analysis.
    Fox BD; Shtraichman O; Langleben D; Shimony A; Kramer MR
    Can J Cardiol; 2016 Dec; 32(12):1520-1530. PubMed ID: 27378592
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sulphonylurea monotherapy for patients with type 2 diabetes mellitus.
    Hemmingsen B; Schroll JB; Lund SS; Wetterslev J; Gluud C; Vaag A; Sonne DP; Lundstrøm LH; Almdal T
    Cochrane Database Syst Rev; 2013 Apr; (4):CD009008. PubMed ID: 23633364
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Additional Use of Prostacyclin Analogs in Patients With Pulmonary Arterial Hypertension: A Meta-Analysis.
    Wang P; Deng J; Zhang Q; Feng H; Zhang Y; Lu Y; Han L; Yang P; Deng Z
    Front Pharmacol; 2022; 13():817119. PubMed ID: 35222031
    [No Abstract]   [Full Text] [Related]  

  • 15. Efficacy and safety of phosphodiesterase type-5 inhibitors for pulmonary arterial hypertension: A meta-analysis focusing on 6MWD.
    He CJ; Chen SJ; Wang J; Zhu CY; Yin YH
    Pulm Pharmacol Ther; 2015 Jun; 32():24-8. PubMed ID: 25843006
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bisphosphonates for breast cancer.
    Pavlakis N; Schmidt R; Stockler M
    Cochrane Database Syst Rev; 2005 Jul; (3):CD003474. PubMed ID: 16034900
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Combination therapy in pulmonary arterial hypertension: a meta-analysis.
    Bai Y; Sun L; Hu S; Wei Y
    Cardiology; 2011; 120(3):157-65. PubMed ID: 22212696
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Methotrexate for induction of remission in refractory Crohn's disease.
    McDonald JW; Tsoulis DJ; Macdonald JK; Feagan BG
    Cochrane Database Syst Rev; 2012 Dec; 12():CD003459. PubMed ID: 23235598
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Combination therapy versus monotherapy for pulmonary arterial hypertension: a meta-analysis.
    Lajoie AC; Lauzière G; Lega JC; Lacasse Y; Martin S; Simard S; Bonnet S; Provencher S
    Lancet Respir Med; 2016 Apr; 4(4):291-305. PubMed ID: 26935844
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Meta-analysis of efficacy and safety of oral theophylline in chronic obstructive pulmonary disease].
    Wang CH; Zhang Q; Li M; Fu PF; Yan ZM; Peng AM; Zhang GL
    Zhonghua Yi Xue Za Zhi; 2010 Mar; 90(8):540-6. PubMed ID: 20367966
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.